Valuation Indivior Pharmaceuticals, Inc.

Stocks

Real-time Estimate Cboe BZX 20:41:49 02/10/2026 +04			5-day change	1st Jan Change
35.44 ^USD	+0.18%		-1.20%	-1.37%

09-17	Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend, Payable on or About November 6, 2026	CI
09-17	Indivior Sets Special Cash Dividend at $8.13 a Share Contingent on Completion of Supernus Merger	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,423	2,969	2,085	1,553	4,480	4,175	-	-
Change	-	22.54%	-29.76%	-25.5%	188.39%	-6.8%	-	-
Enterprise Value (EV) ¹	1,563	2,435	2,008	1,567	4,604	4,163	3,605	2,985
Change	-	55.81%	-17.52%	-21.95%	193.72%	-9.58%	-13.39%	-17.22%
P/E	12.8x	-57.2x	1,527x	-34.5x	21.9x	9.51x	8.62x	7.88x
PBR	-	59.3x	-	-8.02x	-45.8x	-	-	-
PEG	-	0x	-15x	0x	-0x	0x	0.8x	0.84x
Capitalization / Revenue	3.06x	3.29x	1.91x	1.31x	3.62x	3.13x	2.98x	2.8x
EV / Revenue	1.98x	2.7x	1.84x	1.32x	3.72x	3.13x	2.58x	2x
EV / EBITDA	7.74x	10.8x	6.97x	4.64x	10.8x	5.72x	4.56x	3.47x
EV / EBIT	8.36x	11.5x	7.47x	5.02x	11.1x	6.04x	4.89x	3.75x
EV / FCF	4.61x	-10.7x	-4.86x	-196x	-49.5x	8.18x	6.63x	4.83x
FCF Yield	21.7%	-9.32%	-20.6%	-0.51%	-2.02%	12.2%	15.1%	20.7%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.35	-0.38	0.01	-0.36	1.64	3.72	4.105	4.49
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	791	901	1,093	1,188	1,239	1,332	1,400	1,489
EBITDA ¹	202	225	288	338	428	728.4	790.8	859.6
EBIT ¹	187	212	269	312	415	688.8	737.7	795.7
Net income ¹	205	-53	2	-48	210	474.3	530	582.9
Net Debt ¹	-860	-534	-77	14	124	-12.5	-570	-1,191
Reference price ²	17.25	21.75	15.27	12.43	35.88	35.38	35.38	35.38
Nbr of stocks (in thousands)	140,437	136,489	136,551	124,970	124,854	118,014	-	-
Announcement Date	16/02/22	16/02/23	22/02/24	20/02/25	26/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
INDIVIOR PHARMACEUTICALS, INC.	9.51x	3.13x	5.72x	-	4.18B
ELI LILLY AND COMPANY	32.69x	11.85x	24.08x	0.6%	1,025B
JOHNSON & JOHNSON	28.77x	6.4x	17.91x	2.06%	623B
ABBVIE INC.	32.89x	7.71x	15.93x	2.67%	459B
MERCK & CO., INC.	104.62x	5.85x	24.82x	2.37%	355B
ROCHE HOLDING AG	18.99x	4.63x	11.47x	2.87%	336B
NOVARTIS AG	20.13x	5.23x	12.95x	3.06%	270B
ASTRAZENECA PLC	20.27x	4.21x	12x	2.1%	247B
AMGEN INC.	25.72x	6.72x	11.97x	2.48%	220B
GILEAD SCIENCES, INC.	-44.61x	6.5x	25.4x	2.23%	183B
Average	24.90x	6.22x	16.22x	2.27%	372.24B
Weighted average by Cap.	31.71x	7.64x	18.69x	1.95%